Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Other Current Payables: ¥86.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688488 Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
65 GF Score
Price ¥15.00
GF Value ¥24.17
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Aidea Pharmaceutical Group Co Other Current Payables?

Jiangsu Aidea Pharmaceutical Group Co SHSE:688488 -5.00% 65 Other Current Payables is ¥86.2 Mil as of Mar. 2026. GuruFocus rates SHSE:688488 with a GF Score™ of 65/100 and a GF Value™ of ¥24.17 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Jiangsu Aidea Pharmaceutical Group Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥86.2 Mil.

Jiangsu Aidea Pharmaceutical Group Co's quarterly Other Current Payables increased from Sep. 2025 (¥90.6 Mil) to Dec. 2025 (¥98.2 Mil) but then declined from Dec. 2025 (¥98.2 Mil) to Mar. 2026 (¥86.2 Mil).

Jiangsu Aidea Pharmaceutical Group Co's annual Other Current Payables increased from Dec. 2023 (¥25.0 Mil) to Dec. 2024 (¥101.5 Mil) but then declined from Dec. 2024 (¥101.5 Mil) to Dec. 2025 (¥98.2 Mil).

Jiangsu Aidea Pharmaceutical Group Co Other Current Payables Related Terms

Jiangsu Aidea Pharmaceutical Group Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Jiangsu Aidea Pharmaceutical Group Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Aidea Pharmaceutical Group Co Other Current Payables Chart

Jiangsu Aidea Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.89 23.98 24.97 101.54 98.18

Jiangsu Aidea Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.96 95.68 90.58 98.18 86.18
SHSE:688488
65GF Score
Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Aidea Pharmaceutical Group Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥86.2 Mil mean?
Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) has a Other Current Payables of ¥86.2 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors.
Is Jiangsu Aidea Pharmaceutical Group Co's Other Current Payables too high?
Jiangsu Aidea Pharmaceutical Group Co's current Other Current Payables is ¥86.2 Mil. Overall, Jiangsu Aidea Pharmaceutical Group Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Aidea Pharmaceutical Group Co's Other Current Payables compare to VRTX and REGN?
Jiangsu Aidea Pharmaceutical Group Co's Other Current Payables of ¥86.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors. Jiangsu Aidea Pharmaceutical Group Co's current Other Current Payables is ¥86.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Aidea Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥24.17, compared to a current price of ¥15.00 — trading 37.9% below its estimated fair value. The current Other Current Payables is ¥86.2 Mil. Jiangsu Aidea Pharmaceutical Group Co's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488), the current Other Current Payables is ¥86.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥15.00 is trading 37.9% below its estimated GF Value™ of ¥24.17. GuruFocus considers Jiangsu Aidea Pharmaceutical Group Co to be Significantly Undervalued.

Key valuation signals for SHSE:688488:

  • Other Current Payables: ¥86.2 Mil
  • GF Value™: ¥24.17 vs. price of ¥15.00 (37.9% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Aidea Pharmaceutical Group Co Business Description

Address No. 69, Xin Ganquan West Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Group Co Ltd is engaged in the production and sales of human protein products, and also carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents.
65GF Score

Get the complete analysis for SHSE:688488

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.00
Price
¥24.17
GF Value